Hepatic artery embolization Hepatic artery embolization Hepatic artery embolization (HAE), also known as trans-arterial embolization (TAE), is one of the several therapeutic methods to treat primary liver tumors or metastases to the liver. The embolization therapy can reduce the size of the tumor, and decrease the tumor's impact such its hormone production, effectively decreasing symptoms. The treatment was initially developed in the early 1970s. The several types of hepatic artery treatments are based on the observation that tumor cells get nearly all their nutrients from the hepatic artery, while the normal cells of the liver get about 70-80 percent of their nutrients and
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine availability of organs from a deceased person. Any removed parts of the body must be disposed of respectfully in accordance with the wishes of the individual. In addition, there is to be no financial gain arising from the human body or its parts, however adequate compensation for expenses incurred for a medical procedure is not prohibited. The rules relating to consent laid out in "Chapter II" of the Convention also apply in the context of organ transplantation. In accordance with the European Convention on Human Rights, any individual who has suffered damage should have access to fair compensation ("Article 24").